Skip to main content
Clinical Trials/NCT04710004
NCT04710004
Terminated
Not Applicable

Electrophysiological Biomarkers During Invasive Monitoring of Mesial Temporal Lobe Epilepsy Patients.

Emory University1 site in 1 country1 target enrollmentNovember 30, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mesial Temporal Lobe Epilepsy
Sponsor
Emory University
Enrollment
1
Locations
1
Primary Endpoint
Change in Intracranial EEG Recording: Synchrony From Baseline
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

The investigators plan to enroll individuals with medical temporal lobe epilepsy who are undergoing surgical workup with clinically implanted intracranial electrodes. The study intends to administer computerized memory tasks and stimulation during the intracranial Electroencephalography (EEG) monitoring period.

Detailed Description

This is a nonrandomized interventional trial that will apply brain stimulation via clinically implanted intracranial electrodes to subjects with medial temporal lobe epilepsy with the purpose of identifying biomarkers related to the pre-ictal state; to perform an acute parameter search to determine the stimulation pattern that most effectively modifies these biomarkers and to identify changes in memory (free recall) during asynchronous distributed multi-electrode stimulation (ADMES).

Registry
clinicaltrials.gov
Start Date
November 30, 2021
End Date
December 16, 2021
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Robert Gross

Professor

Emory University

Eligibility Criteria

Inclusion Criteria

  • Provision of signed and dated informed consent form
  • Male or female, aged 18-65
  • Diagnosed with lesional or non-lesional mesial temporal (hippocampal) seizure onset confirmed on SEEG monitoring
  • Implanted with depth electrodes for localization of seizure onset with multiple hippocampal electrode arrays
  • Exclusion criteria:
  • Any patient who is unwilling or unable to provide consent
  • Women who are pregnant
  • Patients under 18 years
  • Incarcerated persons

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in Intracranial EEG Recording: Synchrony From Baseline

Time Frame: Baseline, up to 6 weeks postintervention

Synchrony will be compared between baseline/sham and stimulation trials to determine if asynchronous stimulation modulates synchrony during the preictal, ictal or post ictal states. Synchrony is a measure of how any pair of regions communicate with one another. Synchrony is measured as the correlation \[-1 to 1\] between two time series. The investigators anticipate that a decrease in synchrony (correlation approaching 0) is associated with improved outcome.

Change in Intracranial EEG Recording: Spectral Power From Baseline

Time Frame: Baseline, up to 6 weeks postintervention

Spectral power will be compared between baseline/sham and stimulation trials to determine if asynchronous stimulation modulates spectral power during the preictal, ictal or post ictal states. Spectral power is measured in microvolts. A change in either direction from baseline is associated with a better outcome.

Secondary Outcomes

  • Changes in Memory During Brain Stimulation From Baseline(Baseline, up to 6 weeks postintervention)

Study Sites (1)

Loading locations...

Similar Trials